Displaying 101 - 150 of 192 results
Released Company Title Industry Topic
15 May 2025
18:00 CEST
OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
15 May 2025
18:00 CEST
OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
12 May 2025
18:00 CEST
OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
12 May 2025
18:00 CEST
OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
09 May 2025
18:00 CEST
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
09 May 2025
18:00 CEST
OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
25 Apr 2025
18:30 CEST
OXURION Oxurion kondigt stopzetting aan van de transactie van juli 2024 en bevestigt de voortzetting van de gesprekken over het overnameproject aangekondigd in maart 2025 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
25 Apr 2025
18:30 CEST
OXURION Oxurion annonce l'arrêt de la transaction de juillet 2024 et confirme la poursuite des discussions sur le projet d'acquisition annoncé en mars 2025 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
25 Apr 2025
18:30 CEST
OXURION Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
11 Apr 2025
20:05 CEST
OXURION Publication Annual Report - Annual Shareholders' Meeting 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
11 Apr 2025
20:00 CEST
OXURION Publicatie jaarverslag - Jaarlijkse Algemene Vergadering 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
04 Apr 2025
14:00 CEST
OXURION Uitstel Gewone Algemene Vergadering 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
04 Apr 2025
14:00 CEST
OXURION Postponement Annual Shareholders Meeting 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
02 Apr 2025
18:00 CEST
OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
02 Apr 2025
18:00 CEST
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
27 Mar 2025
18:00 CET
OXURION Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
27 Mar 2025
18:00 CET
OXURION Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
27 Mar 2025
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
27 Mar 2025
18:00 CET
OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
24 Mar 2025
18:00 CET
OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
24 Mar 2025
18:00 CET
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
18 Mar 2025
18:30 CET
OXURION Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
18 Mar 2025
18:30 CET
OXURION Oxurion ondertekent intentieverklaring voor de voorgenomen overname van een CRO gespecialiseerd in biometrie 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
18 Mar 2025
18:30 CET
OXURION Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO spécialisée en biométrique 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
18 Mar 2025
18:00 CET
OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
18 Mar 2025
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
04 Mar 2025
19:00 CET
OXURION Oxurion Extends Its Financing Program 20103010 Biotechnology Legal
04 Mar 2025
19:00 CET
OXURION Oxurion verlengt haar financieringsprogramma 20103010 Biotechnology Legal
14 Feb 2025
19:00 CET
OXURION Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane 20103010 Biotechnology Legal
14 Feb 2025
19:00 CET
OXURION Oxurion renforce son Conseil d'Administration avec l'arrivée de Nelly Souleymane 20103010 Biotechnology Legal
14 Feb 2025
19:00 CET
OXURION Oxurion versterkt zijn Raad van Bestuur met de komst van Nelly Souleymane 20103010 Biotechnology Legal
20 Jan 2025
18:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
20 Jan 2025
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Jan 2025
18:00 CET
OXURION Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Jan 2025
18:00 CET
OXURION Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET
OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
06 Jan 2025
18:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
06 Jan 2025
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET
OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
31 Dec 2024
18:00 CET
OXURION Oxurion annonce le report de la signature de la transaction stratégique en raison de discussions en cours 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
31 Dec 2024
18:00 CET
OXURION Oxurion Announces Postponement of Signing for Strategic Transaction Due to Ongoing Discussions 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
31 Dec 2024
18:00 CET
OXURION Oxurion kondigt uitstel aan van ondertekening van strategische transactie wegens lopende besprekingen 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Dec 2024
18:00 CET
OXURION French Authorities Approve Oxurion's Strategic Transaction Under Specific Conditions 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Dec 2024
18:00 CET
OXURION Les autorités françaises approuvent la transaction stratégique d'Oxurion, sous certaines conditions spécifiques 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts